The prestigious Jon J. van Rood Award honors outstanding contributions in the field of hematopoietic transplantation immunology, like graft-vs-leukaemia/tumour effects, or development of innovative therapeutic approaches based on the engineering of immune effector cells. The prize is awarded yearly by the EBMT.
The EBMT Cellular Therapy & Immunobiology Working Party (CTIWP) awarded the Jon van Rood prize to junior PI and applicant for the next CRC1479 funding period Janaki Vinnakota.The award is based on her article in Nature Cancer 2024 „Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome“.
Congratulations!
https://www.ebmt.org/ebmt/news/ebmt-2025-annual-meeting-jon-j-van-rood-award-winners
